miRNAs have previously been identified as powerful biomarkers in a variety of cancers [16], [17], [18], [76], [77], [78], and in this study, the bioinformatics analysis predicted miRNAs which targeted genes expressing the CD3 subunits, including CD3-gamma, Cd3-delta, CD3-epsilon and CD3-zeta. Here, CD3D is linked to cancer.